RAPGEF3 and ovarian carcinoma: Rangarajan et al. demonstrate that upon the stimulation of β2-adrenergic receptor, cAMP induces the adhesion of Ovcar3 ovarian cancer cells through the Epac/Rap1 pathway [34].